Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

A Xochelli, A Agathangelidis, I Kavakiotis, E Minga, LA Sutton, P Baliakas, I Chouvarda, V Giudicelli, I Vlahavas, N Maglaveras, L Bonello, L Trentin, A Tedeschi, P Panagiotidis, C Geisler, AW Langerak, S Pospisilova, DF Jelinek, D Oscier, N...

. 2015 ; 67 (1) : 61-66.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc19036291

Grantová podpora
NT13493 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 2003-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2003-01-01 do Před 1 rokem

Nuext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 % of the cohort). In 291/405 sequences (71.9 %), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity (%GI) was noted in 114/405 (28.1 %) sequences; in 50/114 (43.8 %) sequences, changes in the %GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 %, where caution is warranted.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19036291
003      
CZ-PrNML
005      
20191009140535.0
007      
ta
008      
191009s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00251-014-0812-3 $2 doi
035    __
$a (PubMed)25388851
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Xochelli A $u Xochelli, Aliki. Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
245    10
$a Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia / $c A Xochelli, A Agathangelidis, I Kavakiotis, E Minga, LA Sutton, P Baliakas, I Chouvarda, V Giudicelli, I Vlahavas, N Maglaveras, L Bonello, L Trentin, A Tedeschi, P Panagiotidis, C Geisler, AW Langerak, S Pospisilova, DF Jelinek, D Oscier, N Chiorazzi, N Darzentas, F Davi, P Ghia, R Rosenquist, A Hadzidimitriou, C Belessi, MP Lefranc, K Stamatopoulos
520    9_
$a Nuext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 % of the cohort). In 291/405 sequences (71.9 %), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity (%GI) was noted in 114/405 (28.1 %) sequences; in 50/114 (43.8 %) sequences, changes in the %GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 %, where caution is warranted.
590    __
$a bohemika - dle Pubmed
650    02
$a alely $7 D000483
650    02
$a sekvence aminokyselin $x genetika $7 D000595
650    12
$a hypervariabilní oblasti $x genetika $7 D022801
650    02
$a lidé $7 D006801
650    12
$a chronická lymfatická leukemie $x genetika $x imunologie $x patologie $7 D015451
650    02
$a mutace $7 D009154
650    12
$a prognóza $7 D011379
650    02
$a sekvenční seřazení $7 D016415
700    1_
$a Agathangelidis A
700    1_
$a Kavakiotis I
700    1_
$a Minga E
700    1_
$a Sutton LA
700    1_
$a Baliakas P
700    1_
$a Chouvarda I
700    1_
$a Giudicelli V
700    1_
$a Vlahavas I
700    1_
$a Maglaveras N
700    1_
$a Bonello L
700    1_
$a Trentin L
700    1_
$a Tedeschi A
700    1_
$a Panagiotidis P
700    1_
$a Geisler C
700    1_
$a Langerak AW
700    1_
$a Pospíšilová, Šárka, $d 1969- $7 xx0101843
700    1_
$a Jelinek DF
700    1_
$a Oscier D
700    1_
$a Chiorazzi N
700    1_
$a Darzentas, Nicos $7 xx0238322
700    1_
$a Davi F
700    1_
$a Ghia P
700    1_
$a Rosenquist R
700    1_
$a Hadzidimitriou A
700    1_
$a Belessi C
700    1_
$a Lefranc MP
700    1_
$a Stamatopoulos K
773    0_
$t Immunogenetics $g Roč. 67, č. 1 (2015), s. 61-66 $p Immunogenetics $x 0093-7711 $w MED00002190
773    0_
$p Immunogenetics $g 67(1):61-6, 2015 Jan
910    __
$a ABA008 $b sig $y 4 $z 0
990    __
$a 20191009140953 $b ABA008
991    __
$a 20191009140953 $b ABA008
999    __
$a ok $b bmc $g 1453154 $s 1074851
BAS    __
$a 3
BMC    __
$a 2015 $b 67 $c 1 $d 61-66 $x MED00002190 $i 0093-7711 $m Immunogenetics
GRA    __
$a NT13493 $p MZ0
LZP    __
$a NLK 2019/lp

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...